Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Parke-Davis discusses development of potent, irreversible EGF receptor TK inhibitors

June 30, 1998

Oxidized phenolic compounds with an unexpected mechanism of action

June 30, 1998

U.S. patent licensed to Avax Technologies issued for anticancer compounds

June 30, 1998

Various schedules and doses of DMDC explored in phase I

June 29, 1998

Pyrazoloacridine evaluated in patients with pancreatic and hepatobiliary cancer

June 29, 1998

Preclinical studies with doranidazole summarized

June 29, 1998

Modulators of drug/multidrug resistance from Lilly

June 29, 1998

Tricyclic antitumor compounds developed at Schering-Plough

June 29, 1998

New class of FPTase inhibitors discovered at Merck & Co.

June 29, 1998

Melphalan derivative pinpointed for further study

June 29, 1998

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...